BOTOX
April 1st, 2002
BY PHILIP FINE
BOTOX can now be sold as a temporary wrinkle remover in America, after the popular injection received approval as a cosmetic by the US Food and Drug Administration. The product, which short-circuits electrical messages from the brain to facial nerve endings, is derived from a purified form of the toxin that causes botulism. FDA approval is specifically for frown lines between the eyebrows. Already two decades old, Botox was
injected 1.6 million times last year by American doctors, at an average cost of US$400 (GBPounds 277) per procedure. The ...
Full access to this article can be arranged with permission from the client that first ordered it. Please contact us to request access. Entries are uploaded to our archive at least one year after being published by a client – free access is restricted to International News Services journalists for background research only. The article date indicates when copy was filed to a client, not when posted to this archive. Upon client requests, International News Services will remove such articles from the archive or not upload them in the first place. They are included to demonstrate the breadth of topics undertaken by the agency and also to help promote clients’ coverage.